Judy DiClemente | Insight Communications Investor Relations |
Nikhil Lalwani | President and CEO |
Stephen Carey | Chief Financial Officer |
Elliot Wilbur | Raymond James |
Vamil Divan | Guggenheim Securities |
Brandon Folkes | Cantor Fitzgerald |
Greg Fraser | Truist Securities |
Oren Livnat | H.C. Wainwright |
Good day, everyone. And welcome to today’s ANI Pharmaceuticals Q1 2023 Earnings Call. At this time, all participants are in a listen-only mode. Later you will have the opportunity to ask questions during the question-and-answer period. [Operator Instructions]